Image For Activity Cover
Subendocardial Involvement as an Underrecognized LGE Subtype Related to Adverse Outcomes in Hypertrophic Cardiomyopathy - JIMG September 2023
Late gadolinium enhancement (LGE) has been established as an independent predictor for adverse outcomes in hypertrophic cardiomyopathy (HCM). However, the prevalence and clinical significance of some LGE subtypes have not been well demonstrated.
Y.S. Chandrashekhar, MD, DM, FACC

CME Editor
Kenneth A. Ellenbogen, MD 

Michael H. Beasley, MD, FACC

Important Dates
Date of Release: September 4, 2023
Term of Approval/Date of CME/MOC Expiration: September 3, 2024
Availability: On-Demand
Expires on Sep 03, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
Android App Download IOS App Download Powered By